top of page
AdobeStock_237330799 (1).jpeg

We are on a mission to address the most challenging and unaddressed diseases impacting humankind.

PulmoSIM%20Tx_Image%20with%20overlay_3_e

ABOUT

PulmoSIM Therapeutics is the pharmaceutical subsidiary of VeriSIM Life, developing breakthrough therapies for rare and progressive respiratory diseases to improve patient outcomes and quality of life. Our immediate focus is to address the unmet needs in pulmonary arterial hypertension (PAH) and idiopathic pulmonary fibrosis (IPF) by targeting the underlying biology to alleviate the need for combination therapies.


We leverage BIOiSIM, a first-in-class artificial intelligence bio-simulation platform developed by VeriSIM Life, to accelerate our drug development by bridging the translational gap between preclinical and clinical phases.

ABOUT

PIPELINE

PulmoSIM Therapeutics’ pipeline includes 2 drug assets. 

PT001 is a U.S. Food & Drug Administration designated Orphan Drug and has successfully completed preclinical study. PT001 has demonstrated positive efficacy with key disease-reversal data for the treatment of PAH. The monotherapy differs significantly from current PAH combination therapies by targeting the disease’s underlying biology. We are working hand-in-hand with a world-class strategic advisory board and clinical and manufacturing partners to rapidly transition the program to clinical studies.

PT002 is undergoing advanced preclinical study for the treatment of IPF.  

149067 - Pulmosim pipeline table - Super
PIPELINE
Jo%20Varshney%20new%20overlay_edited.jpg

Dr. Jo Varshney DVM, Ph.D.

CEO & Founder

LI-In-Bug_black and white.png
Dr. Vivek Gupta_overlay.jpg

Dr. Vivek Gupta, Ph.D.

Scientific Founder

LI-In-Bug_black and white.png
Dr. Eva S. Nozik_overlay.jpg

Dr. Eva S. Nozik, MD

Strategic Advisor

LI-In-Bug_black and white.png
Dr. Samir Mitragotri_overlay.jpg

Dr. Samir Mitragotri, Ph.D.

Strategic Advisor

LI-In-Bug_black and white.png
Dr. Hugh Smyth_overlay.jpg

Dr. Hugh Smyth, Ph.D.

Strategic Advisor

LI-In-Bug_black and white.png

TEAM & ADVISORY BOARD

TEAM
AdobeStock_636263973.jpeg

PRESS & NEWS

PRESS & EVENTS
CONTACT
AdobeStock_617436262.jpeg

INTERESTED IN PARTNERING WITH US?

Thanks for submitting!

  • Black LinkedIn Icon
bottom of page